Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov;41(8):1983-1992.
doi: 10.1002/nau.24936. Epub 2022 May 5.

Barriers and facilitators to overactive bladder therapy adherence

Ekene A Enemchukwu  1 , Leslee L Subak  2 , Alayne Markland  3
Affiliations
Review

Barriers and facilitators to overactive bladder therapy adherence

Ekene A Enemchukwu et al. Neurourol Urodyn. 2022 Nov.

Abstract

Aims: To provide an overview of the barriers and facilitators to overactive bladder (OAB) therapy initiation and adherence.

Methods: A PubMed and Embase literature search was conducted to identify barriers to OAB therapy adherence.

Results: OAB therapy adherence is associated with improvements in urinary symptoms, and quality of life with reductions in annual costs for OAB-related expenditures. However, adherence rates to behavioral therapies are as low as 32% at 1 year, only 15%-40% of treated patients remain on oral medications at 1 year due to several factors (e.g., inadequate efficacy, tolerability, and cost), and 5%-10% of OAB patients progress to advanced therapies. While some common barriers to therapy adherence are often fixed (e.g., costs, lack of efficacy, time, side effects, treatment fatigue), many are modifiable (e.g., lack of knowledge, poor relationships, negative experiences, poor communication with providers). Patient-centered care may help address some modifiable barriers. Emerging data demonstrate that patient-centered care in the form of treatment navigators improves OAB therapy adherence and progression to advanced therapies in the appropriate patient.

Conclusions: There are numerous modifiable barriers to OAB therapy adherence. A patient-centered lens is needed to elicit patient goals, establish realistic treatment expectations, and tailor therapy to improve therapy adherence, optimize outcomes, and reduce healthcare expenditures. Further research is needed to develop and study low-cost, scalable solutions.

Keywords: behavioral therapy; overactive bladder; patient-centered care; pharmacotherapy; therapy adherence; third-line therapy; urinary incontinence.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Strategies for improving OAB therapy adherence: an adapted conceptual framework., BT, bladder training; PFMT, pelvic floor muscle training; QOL, quality of life; SDM, shared decision-making; SDOH, social determinants of health; SES, socioeconomic status.
See this image and copyright information in PMC

References

    1. Haylen BT, de Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J. 2010;21:5–26. - PubMed
    1. Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20:327–336. - PubMed
    1. Coyne KS, Sexton CC, Bell JA, et al. The prevalence of lower urinary tract symptoms (LUTS) and overactive bladder (OAB) by racial/ethnic group and age: results from OAB-POLL. Neurourol Urodyn. 2013;32:230–237. - PubMed
    1. Lightner DJ, Gomelsky A, Souter L, Vasavada SP. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment 2019. J Urol. 2019;202(3):558–563. - PubMed
    1. Coyne KS, Sexton CC, Irwin DE, Kopp ZS, Kelleher CJ, Milsom I. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int. 2008;101:1388–1395. - PubMed